Exaggerated pulmonary hypertension with monocrotaline in rats susceptible to chronic mountain sickness

Journal of Applied Physiology

Volumn 83, Issue 1, 1997, Pages 25-31

  Colice, Gene L ^a   Hill, Nicholas ^b   Lee, Yan Jie ^b   Du, Hongkai ^b   Klinger, James ^b   Leiter, James C ^b   Ou, Lo Chang ^b  

^a 3M COMPANY   (United States)

^b NONE

Author keywords

Chronic hypoxia; Pulmonary vascular histology; Ventilation

Indexed keywords

MONOCROTALINE;

ALTITUDE DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; HEART VENTRICLE REMODELING; LUNG ARTERY PRESSURE; MALE; NONHUMAN; PRESSURE MEASUREMENT; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RAT; STRAIN DIFFERENCE;

EID: 0030848143     PISSN: 87507587     EISSN: None     Source Type: Journal    
DOI: 10.1152/jappl.1997.83.1.25     Document Type: Article

References (37)

1. Atkinson, J. E., J. W. Olson, R. J. Altiere, and M. N. Gillespie. Evidence that hypoxic pulmonary vascular remodeling in rats is polyamine dependent. J. Appl. Physiol. 62: 1562-1568, 1987.
2. Bartlett, D., and S. M. Tenney. Control of breathing in experimental anemia. Respir. Physiol. 10: 384-395, 1970.
3. A-receptor antagonist prevents and reverses chronic hypoxia-induced pulmonary hypertension in rat. Am. J. Physiol. 269 (Lung Cell. Mol. Physiol. 13): L690-L697, 1995.
4. Ghodsi, F., and J. A. Will. Changes in pulmonary structure and function induced by monocrotaline intoxication. Am. J. Physiol. 240 (Heart Circ. Physiol. 9): H149-H155, 1981.
5. Heath, D., H. Moosavi, and P. Smith. Ultrastructure of high altitude pulmonary edema. Thorax 28: 694-700, 1973.
6. Hill, N. S., P. Jederlinic, and J. Gagnon. Supplemental oxygen reduces right ventricular hypertrophy in monocrotaline-injected rats. J. Appl. Physiol. 66: 1642-1648, 1989.
7. Hilliker, K. S., T. G. Bell, and R. A. Roth. Pneumotoxicity and thrombocytopenia after single injection of monocrotaline. Am. J. Physiol. 242 (Heart Circ. Physiol. 11): H573-H579, 1982.
8. Hislop, A., and L. Reid. New findings in pulmonary arteries of rats with hypoxia-induced pulmonary hypertension. Br. J. Exp. Pathol. 57: 542-553, 1976.
9. Hoorn, C. M., and R. A. Roth. Monocrotaline pyrrole-induced changes in angiotensin-converting enzyme activity of cultured pulmonary artery endothelial cells. Br. J. Pharmacol. 110: 597-603, 1993.
10. Hung, K. S., J. C. McKenzie, L. Mattioli, R. M. Klein, and A. K. Poulose. Scanning electron microscopy of pulmonary vascular endothelium in rats with hypoxia-induced hypertension. Acta Anat. 126: 13-20, 1986.
11. Ilkiw, R., L. Todorovich-Hunter, K. Maruyama, J. Shin, and M. Rabinovitch. SC-39026, a serine elastase inhibitor, prevents muscularization of peripheral arteries, suggesting a mechanism of monocrotaline-induced pulmonary hypertension in rats. Circ. Res. 64: 814-825, 1989.
12. Kay, J. M., P. Smith, and D. Heath. Electron microscopy of Crotalaria pulmonary hypertension. Thorax 24: 511-525, 1969.
13. Lai, Y. L., J. W. Olson, and M. N. Gillespie. Ventilatory dysfunction precedes pulmonary vascular changes in monocrotaline-treated rats. J. Appl. Physiol. 70: 561-566, 1991.
14. Lalich, J. J., W. D. Johnson, T. J. Raczniak, and R. C. Shumaker. Fibrin thrombosis in monocrotaline pyrrole-induced or pulmonary in rats. Arch. Pathol. Lab. Med. 101: 69-73, 1977.
15. Langleben, D., R. C. Jones, M. J. Aronovitz, N. S. Hill, L. C. Ou, and L. M. Reid. Pulmonary artery structural changes in two colonies of rats with different sensitivity to chronic hypoxia. Am. J. Pathol. 128: 61-66, 1987.
16. Maruyama, K., C. Ye, M. Woo, H. Venkatacharya, L. D. Lines, M. M. Silver, and M. Rabinovitch. Chronic hypoxic pulmonary hypertension in rats and increased elastrolytic activity. Am. J. Physiol. 261 (Heart Circ. Physiol. 30): H1716-H1726, 1991.
17. Merkow, L., and J. Kleinerman. An electron microscopic study of pulmonary vasculitis induced by monocrotaline. Lab. Invest. 15: 547-564, 1961.
18. Meyrick, B., W. Gamble, and L. Reid. Development of Crotalaria pulmonary hypertension: hemodynamic and structural study. Am. J. Physiol. 239 (Heart Circ. Physiol. 8): H692-H702, 1980.
19. Meyrick, B., and L. Reid. The effect of continued hypoxia on rat pulmonary arterial circulation. Lab. Invest. 38: 188-199, 1978.
20. Meyrick, B., and L. Reid. Development of pulmonary arterial changes in rats fed Crotalaria spectabilis. Am. J. Pathol. 94: 37-50, 1979.
21. Miyauchi, T., R. Yorikane, S. Sakai, T. Sakurai, M. Okada, M. Nishikibe, M. Yano, I. Yamaguchi, Y. Sugishita, and K. Goto. Contribution of endogenous endothelin-1 to the progression of cardiopulmonary alterations in rats with monocrotaline-induced pulmonary hypertension. Circ. Res. 73: 887-897, 1993.
22. Olson, J. W., A. D. Hacker, R. J. Altiere, and M. N. Gillespie. Polyamines and the development of monocrotaline-induced pulmonary hypertension. Am. J. Physiol. 247 (Heart Circ. Physiol. 16): H682-H685, 1984.
23. Ono, S., and N. F. Voelkel. PAF antagonists inhibit monocrotaline-induced lung injury and pulmonary hypertension. J. Appl. Physiol. 71: 2483-2492, 1991.
24. Ono, S., J. Y. Westcott, and N. F. Voelkel. PAF antagonists inhibit pulmonary vascular remodeling induced by hypobaric hypoxia in rats. J. Appl. Physiol. 73: 1084-1092, 1992.
25. Ou, L. C., J. Chen, E. Fiore, J. C. Leiter, T. Brinck-Johnson, G. F. Birchard, G. Clemons, and R. P. Smith. Ventilatory and hematopoietic responses to chronic hypoxia in two rat strains. J. Appl. Physiol. 72: 2354-2363, 1992.
26. Ou, L. C., N. S. Hill, and S. M. Tenney. Ventilatory responses and blood gases in susceptible and resistant rats to high altitude. Respir. Physiol. 58: 161-170, 1984.
27. Ou, L. C., G. L. Sardella, N. S. Hill, and S. M. Tenney. Acute and chronic pulmonary presser responses to hypoxia: the role of blunting in acclimatization. Respir. Physiol. 64: 81-91, 1986.
28. Ou, L. C., and R. P. Smith. Probable strain differences in susceptibilities and cardiopulmonary responses to chronic hypoxia. Respir. Physiol. 53: 367-377, 1983.
29. Rabinovitch, M., W. Gamble, A. S. Nadas, O. S. Miettinen, and L. Reid. Rat pulmonary circulation after chronic hypoxia: hemodynamic and structural features. Am. J. Physiol. 236 (Heart Circ. Physiol. 5): H818-H827, 1979.
30. Scott, K. W. M., G. R. Borer, E. Leach, and I. P. F. Mungall. Pulmonary ultrastructural changes in hypoxic rats. J. Pathol. 126: 27-32, 1978.
31. Sobin, S. S. Hypoxia and the pulmonary microvasculature. Chest 93, Suppl. 3: 155S-156S, 1988.
32. Sobin, S. S., H. M. Tremer, J. D. Hardy, and H. P. Chiodi. Changes in arterioles in acute and chronic hypoxic pulmonary hypertension and recovery in rats. J. Appl. Physiol. 55: 1445-1455, 1983.
33. Stenmark, K. R., M. L. Morganroth, L. K. Remigio, N. F. Voelkel, R. C. Murphy, P. M. Henson, M. M. Mathias, and J. T. Reeves. Alveolar inflammation and arachidonate metabolism in monocrotaline-induced pulmonary hypertension. Am. J. Physiol. 248 (Heart Circ. Physiol. 17): H859-H866, 1985.
34. Todorovich-Hunter, L., H. Dodo, C. Ye, L. McCready, F. W. Keeley, and M. Rabinovitch. Increased pulmonary artery elastrolytic activity in adult rats with monocrotaline-induced progressive hypertensive pulmonary vascular disease compared with infant rats with nonprogressive disease. Am. Rev. Respir. Dis. 146: 213-223, 1992.
35. Valdivia, E., J. J. Lalich, Y. Hayashi, and J. Sonnad. Alterations in pulmonary alveoli after a single injection of monocrotaline. Arch. Pathol. 84: 64-76, 1967.
36. Vender, R. L. Chronic hypoxic pulmonary hypertension. Chest 106: 236-243, 1994.
37. Ye, C., and M. Rabinovitch. Inhibition of elastolysis by SC-37698 reduces development and progression of monocrotaline pulmonary hypertension. Am. J. Physiol. 261 (Heart Circ. Physiol. 30): H1255-H1267, 1991.